Lightpoint Medical
Lightpoint Medical, acquired by Telix Pharmaceuticals, is a medical technology company innovating in targeted cancer surgery by integrating AI, nuclear imaging, and miniaturized sensors. Their flagship product, the SENSEI® drop-in gamma probe, enhances surgical precision by enabling real-time cancer detection during robotic surgeries, improving patient outcomes and reducing healthcare costs. The company collaborates with leading international cancer centers and surgeons, advancing applications in prostate, bladder, lung, cervical, and colorectal cancer surgeries. Lightpoint's technology combines cancer-targeted imaging agents with AI to visualize cancer extent intraoperatively, representing a paradigm shift in cancer surgery treatment.
Lightpoint Medical
Lightpoint Medical, acquired by Telix Pharmaceuticals, is a medical technology company innovating in targeted cancer surgery by integrating AI, nuclear imaging, and miniaturized sensors. Their flagship product, the SENSEI® drop-in gamma probe, enhances surgical precision by enabling real-time cancer detection during robotic surgeries, improving patient outcomes and reducing healthcare costs. The company collaborates with leading international cancer centers and surgeons, advancing applications in prostate, bladder, lung, cervical, and colorectal cancer surgeries. Lightpoint's technology combines cancer-targeted imaging agents with AI to visualize cancer extent intraoperatively, representing a paradigm shift in cancer surgery treatment.